Patents by Inventor Kenny Hansson

Kenny Hansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9433664
    Abstract: The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII; (2) PCC; and (3) a three factor combination of FH, FX and FVIIa. The clotting factor treatment can be administered in combination with fibrinogen. The clotting factor(s) can be recombinant human clotting factor(s).
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: September 6, 2016
    Assignee: MEDIMMUNE LIMITED
    Inventors: Ann Lovgren, Kenny Hansson